Could REGEN-COV’s New US FDA Emergency Use Authorization Revive COVID-19 Prophylaxis Pipeline?

 
• By Bridget Silverman
  
Prophylaxis
The post-exposure prophylaxis EUA highlighted the needs of immunocompromised patients, Regeneron's president said. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet